Nrx Pharmaceuticals, Inc.
NRXP
Revenue
0.00
0.000.00%
-Assets
5.26M
▲1.48M▲38.97%
3 Months ChangeLiabilities
23.66M
▲4.80M▲25.44%
3 Months ChangeFree Cash Flow
-6.09M
▲4.29M▲41.32%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001437749-24-032705
2024-10-15
Form 8-K
ID: 0001437749-24-031268
2024-10-11
Form 8-K
ID: 0001437749-24-031133
2024-08-20
Form 8-K
ID: 0001437749-24-027383
2024-08-15
Form 8-K
ID: 0001437749-24-026908
2024-08-14
Form 8-K
ID: 0001437749-24-026888
2024-08-14
Form 10-Q
ID: 0001437749-24-026847
2024-08-12
Form 8-K
ID: 0001437749-24-026107
2024-06-27
Form 8-K
ID: 0001104659-24-075722
2024-06-20
Form 8-K
ID: 0001558370-24-009369